Japan News
-
Lupin, Nichi-Iko unite to market biosimilar Etanercept in Japan
Japan | News | 0 Comment | 18 Jun, 2018
Pharma major Lupin and Nichi-Iko announced that the two companies have entered into an agreement for the distribution, promotion and sale of Lupin’s recently-filed biosimilar Etanerce...Read more
-
Sage Therapeutics, Shionogi ink deal for MDD treatment
Japan | News | 0 Comment | 17 Jun, 2018
US-based Sage Therapeutics, and Japan's Shionogi recently announced they have entered into a strategic collaboration for the clinical development and commercialization of SAGE217 for t...Read more
-
AbbVie, Eisai launch auto-injector drug delivery pen
Japan | News | 0 Comment | 15 Jun, 2018
AbbVie has partnered with Eisai and its gastrointestinal diseases unit EA Pharma to introduce an auto-injection delivery pen for Humira drug. The auto-injector system is available in two va...Read more
-
NirogStreet raises $ 300K from Japanese venture
Japan | News | 0 Comment | 13 Jun, 2018
India’s first tech induced Ayurveda platform, NirogStreet raising USD 300k from the Japanese venture fund Spiral Ventures to strengthen technology. With maximum focus on tech...Read more
-
Japan | News | 0 Comment | 12 Jun, 2018
Singapore – VistaGen Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases an...Read more
-
Fluence Analytics announces partnership with Nihon Rufuto
Japan | News | 0 Comment | 08 Jun, 2018
Fluence Analytics, a manufacturer of industrial and laboratory analytics products has announced that it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializin...Read more
-
Verastem, Yakult Honsha Co. Ltd sign exclusive license agreement
Japan | News | 0 Comment | 07 Jun, 2018
Verastem, Inc. and Yakult Honsha Co., Ltd. have announced their entry into an exclusive licensing agreement for Yakult to develop and commercialize Verastem’s duvelisib, a first-in-cl...Read more
-
GHIT Fund names Hiroki Nakatani as Board Chair
Japan | News | 0 Comment | 07 Jun, 2018
The Global Health Innovative Technology (GHIT) Fund has announced the appointment of Hiroki Nakatani, MD, PhD, MHPEd, former World Health Organization (WHO) assistant director-general, to t...Read more
-
USFDA grants Priority Review to Astellas's NDA for Gilteritinib
Japan | News | 0 Comment | 05 Jun, 2018
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Priority Review, the company's New Drug Application (NDA) for gilteritin...Read more
-
Scientists use RFID chips to track biological samples
Japan | News | 0 Comment | 01 Jun, 2018
Researchers in the U.S. and Japan plan to use Radio frequency identification (RFID) chips for keeping track of organoids, samples of human tissue that mimic pieces of organs and are grown f...Read more
-
Telix, Osaka University receive funding for alpha nuclide research
Japan | News | 0 Comment | 31 May, 2018
Singapore- Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals...Read more
-
Eisai, Merck provide Update on sNDA for Lenvatinib
Japan | News | 0 Comment | 25 May, 2018
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has extended the action date for the suppleme...Read more
-
Eisai, Purdue to present latest Clinical Data on Lemborexant
Japan | News | 0 Comment | 23 May, 2018
Eisai Co., Ltd. and Purdue Pharma L.P. announced they will present the latest data from two key Phase I clinical studies (Study 108 and Study 106) of investigational sleep/wake regulation a...Read more
-
AstraZeneca submits sNDA for Forxiga in Japan
Japan | News | 0 Comment | 22 May, 2018
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for the use of Forxiga (...Read more
-
Study shows new possibilities with cardiac T-high sensitive test
Japan | News | 0 Comment | 21 May, 2018
Singapore – Results published in the International Journal of Cardiology show that the 0-hour/1-hour algorithm using the Roche cardiac Troponin T-high sensitive test is...Read more
-
Takeda Divests Techpool to Joint-Venture Partners in China
Japan | News | 0 Comment | 21 May, 2018
Japan's Takeda Pharmaceutical recently announced it has entered into an agreement to sell its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma Co (Techpool), a leader i...Read more
-
Japan approves stem cell based trials for heart treatment
Japan | News | 0 Comment | 17 May, 2018
A special health ministry panel gave Osaka University the approval to carry out a study involving the use of induced pluripotent stem (iPS) cells to treat heart failure. This would be ...Read more
-
Platelet BioGenesis licenses induced pluripotent stem cell technology
Japan | News | 0 Comment | 14 May, 2018
Platelet BioGenesis, a pioneer in the production of functional human platelets from stem cells, has announced it has licensed patents related to induced pluripotent stem cells (“iPS c...Read more
